AI-generated summary
The authors used an in vitro model of diabetes-like glucose neurotoxicity in Neuro 2A cells and tested red light photobiomodulation at 660 nm. They report that the light increased cell viability and neurite outgrowth, with the effect linked to AKT activation. The study was conducted in cultured cells rather than in people or animals.
- Who or what was studied
- Neuro 2A cells cultured under high glucose conditions (in vitro model); no human or animal participants
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in an in vitro cell model, so results may not translate to living patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 1.6 J/cm2
- Power
- 30 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.